000 | 01794 a2200493 4500 | ||
---|---|---|---|
005 | 20250517230832.0 | ||
264 | 0 | _c20190405 | |
008 | 201904s 0 0 eng d | ||
022 | _a1366-5804 | ||
024 | 7 |
_a10.1080/1354750X.2018.1499127 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMirna, Moritz | |
245 | 0 | 0 |
_aMulti-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI). _h[electronic resource] |
260 |
_bBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals _cDec 2018 |
||
300 |
_a773-780 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAortic Valve Stenosis _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
650 | 0 | 4 |
_aFatty Acid Binding Protein 3 _xblood |
650 | 0 | 4 | _aHemodynamics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-1 Receptor-Like 1 Protein _xblood |
650 | 0 | 4 |
_aMembrane Proteins _xblood |
650 | 0 | 4 |
_aNeoplasm Proteins _xblood |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTranscatheter Aortic Valve Replacement |
650 | 0 | 4 |
_aalpha-2-HS-Glycoprotein _xanalysis |
700 | 1 | _aWernly, Bernhard | |
700 | 1 | _aPaar, Vera | |
700 | 1 | _aJung, Christian | |
700 | 1 | _aJirak, Peter | |
700 | 1 | _aFigulla, Hans-Reiner | |
700 | 1 | _aKretzschmar, Daniel | |
700 | 1 | _aFranz, Marcus | |
700 | 1 | _aHoppe, Uta C | |
700 | 1 | _aLichtenauer, Michael | |
700 | 1 | _aLauten, Alexander | |
773 | 0 |
_tBiomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals _gvol. 23 _gno. 8 _gp. 773-780 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/1354750X.2018.1499127 _zAvailable from publisher's website |
999 |
_c28665170 _d28665170 |